Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital of the RWTH Aachen, Aachen, Germany.
Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital of the RWTH Aachen, Aachen, Germany.
Lancet. 2014 Apr 5;383(9924):1222-9. doi: 10.1016/S0140-6736(13)62411-3. Epub 2014 Jan 17.
In-patient treatment (IP) is the treatment setting of choice for moderately-to-severely ill adolescents with anorexia nervosa, but it is costly, and the risks of relapse and readmissions are high. Day patient treatment (DP) is less expensive and might avoid problems of relapse and readmission by easing the transition from hospital to home. We investigated the safety and efficacy of DP after short inpatient care compared with continued IP.
For this multicentre, randomised, open-label, non-inferiority trial, we enrolled female patients (aged 11-18 years) with anorexia nervosa from six centres in Germany. Patients were eligible if they had a body-mass index (BMI) below the tenth percentile and it was their first admission to hospital for anorexia nervosa. We used a computer-generated randomisation sequence to randomly assign patients to continued IP or DP after 3 weeks of inpatient care (1:1; stratified for age and BMI at admission). The treatment programme and treatment intensity in both study groups were identical. The primary outcome was the increase in BMI between the time of admission and a 12-month follow-up adjusted for age and duration of illness (non-inferiority margin of 0·75 kg/m(2)). Analysis was done by modified intention to treat. This trial is registered with the International Standard Randomised Controlled Trial Number Register, number ISRCTN67783402, and the Deutsches Register Klinischer Studien, number DRKS00000101.
Between Feb 2, 2007, to April 27, 2010, we screened 660 patients for eligibility, 172 of whom we randomly allocated to treatment: 85 to IP and 87 to DP. DP was non-inferior to IP with respect to the primary outcome, BMI at the 12-month follow-up (mean difference 0·46 kg/m(2) in favour of DP (95% CI, -0·11 to 1·02; pnon-inferiority<0·0001). The number of treatment-related serious adverse events was similar in both study groups (eight in the IP group, seven in the DP group). Three serious adverse events in the IP group and two in the DP group were related to suicidal ideation; one patient in the DP attempted suicide 3 months after she was discharged.
DP after short inpatient care in adolescent patients with non-chronic anorexia nervosa seems no less effective than IP for weight restoration and maintenance during the first year after admission. Thus, DP might be a safe and less costly alternative to IP. Our results justify the broad implementation of this approach.
German Ministry for Education and Research.
住院治疗(IP)是中重度厌食症青少年的首选治疗方案,但费用较高,且复发和再入院的风险较高。日间治疗(DP)费用较低,通过缓解从医院到家庭的过渡,可能避免复发和再入院的问题。我们研究了短期住院治疗后 DP 与持续 IP 相比的安全性和疗效。
这是一项多中心、随机、开放标签、非劣效性试验,我们招募了来自德国 6 个中心的患有厌食症的女性患者(年龄 11-18 岁)。如果患者的 BMI 低于第 10 百分位数且这是他们首次因厌食症住院,他们就符合入组条件。我们使用计算机生成的随机序列将患者随机分配到住院治疗 3 周后继续 IP 或 DP(1:1;按入院时的年龄和 BMI 分层)。两组的治疗方案和治疗强度相同。主要结局是调整年龄和发病时间后,从入院到 12 个月随访时 BMI 的增加(非劣效性边界为 0.75kg/m2)。分析采用意向治疗进行修正。该试验在国际标准随机对照试验注册中心(ISRCTN)注册,编号为 ISRCTN67783402,在德国临床试验注册中心(DRKS)注册,编号为 DRKS00000101。
在 2007 年 2 月 2 日至 2010 年 4 月 27 日期间,我们对 660 名患者进行了筛选,其中 172 名符合入组条件,将其随机分配至治疗组:85 名至 IP 组,87 名至 DP 组。DP 在主要结局(12 个月随访时的 BMI)方面不劣于 IP(DP 组更优,差值为 0.46kg/m2(95%CI,-0.11 至 1.02;p 非劣效性<0.0001)。两组中与治疗相关的严重不良事件数量相似(IP 组 8 例,DP 组 7 例)。IP 组中有 3 例严重不良事件与自杀意念有关,DP 组中有 2 例与自杀意念有关;1 例 DP 组患者在出院后 3 个月自杀未遂。
在非慢性厌食症青少年患者中,短期住院治疗后进行 DP 治疗在入院后第一年恢复和维持体重方面似乎并不逊于 IP。因此,DP 可能是 IP 的一种安全且成本较低的替代方案。我们的结果证明了这种方法的广泛应用是合理的。
德国联邦教育与研究部。